Why "Reasonable Care" Is Your Best Defense
Every US importer has a statutory obligation under 19 USC §1484 to use reasonable care when classifying, valuing, and declaring imported goods. This is not a guideline. It is the legal standard CBP applies when evaluating whether an importer's practices are compliant — and it is the standard CBP uses when deciding whether errors warrant penalties or leniency.
Reasonable care is also the most misunderstood concept in trade compliance.
What reasonable care is not
Reasonable care is not perfection. CBP does not expect every classification to be correct, every valuation to be precise to the penny, or every origin claim to be unassailable. Errors happen. Tariff schedules are complex. Product characteristics change. Supply chains shift.
Reasonable care is not a checklist. There is no CBP form that, once completed, certifies reasonable care. The standard is contextual — what constitutes reasonable care for a Fortune 500 importer with a dedicated trade compliance team differs from what is reasonable for a small business importing a single product category.
Reasonable care is not something you demonstrate after the fact. You cannot reconstruct reasonable care during an audit. If the evidence of your care doesn't exist at the time the entry is filed, it doesn't exist.
What reasonable care actually is
Reasonable care is demonstrable process.
CBP has published guidance — most notably in the Informed Compliance Publication "What Every Member of the Trade Community Should Know About: Reasonable Care" — that identifies the factors CBP considers. They reduce to a core question: Did the importer have a system for making compliance decisions, and did that system produce a record?
The components:
Classification process. The importer can explain how each product was classified. Not just the heading — the reasoning. Which General Rule of Interpretation applied. Which Chapter or Section notes were consulted. Whether binding rulings were checked. If a product was classified by analogy to a similar product, the basis for that analogy.
Valuation methodology. The importer can explain how transaction value was determined. If additions or deductions were made, the basis for each. If the transaction involves related parties, the method used to establish that the price reflects arm's-length terms.
Origin determination. For goods claiming preferential treatment, the importer can produce the certificate of origin, the qualification methodology, and the supporting records. For non-preferential origin, the importer can explain the country-of-origin determination.
Recordkeeping. All of the above is retained for five years from the date of entry and can be produced on demand.
Ongoing diligence. Classification and valuation decisions are reviewed when circumstances change — new products, new suppliers, new tariff rates, regulatory updates. Reasonable care is not a one-time exercise.
The four audit dimensions
When CBP conducts a Focused Assessment, they evaluate the importer across these same dimensions: classification, valuation, origin, and recordkeeping. The assessment has two phases — the Pre-Assessment Survey (PAS), which reviews the importer's internal controls, and the Assessment Compliance Testing (ACT), which tests actual transactions against those controls.
The PAS phase is where reasonable care is most directly evaluated. CBP reviewers look at:
- Whether the importer has written classification procedures
- Whether valuation decisions are documented and reviewed
- Whether origin determinations are supported by records
- Whether there is an internal audit or review process
- Whether the importer monitors regulatory changes affecting their imports
- Whether errors, when found, are voluntarily disclosed and corrected
An importer who has these controls in place — even imperfectly — is demonstrating reasonable care. An importer who has correct entries but no documented process behind them has a harder conversation with CBP.
The five-year look-back
CBP's statutory authority to review entries extends five years from the date of entry. This is why reasonable care must be continuous.
Consider an importer who classified a product correctly in 2022 based on institutional knowledge. The employee who made the classification left the company in 2023. In 2026, CBP opens a Focused Assessment and asks for the classification rationale. The importer has the correct classification on file. They do not have the reasoning.
This is the gap that the upstream problem creates over time. Each entry filed without documented reasoning is a future audit liability. The entries accumulate. The employees rotate. The institutional knowledge degrades. Five years of entries with correct results and no evidence of process become five years of exposure.
The importers who document their reasoning at the time of each decision — not retroactively, not annually, but continuously — are building a five-year evidence trail that works in their favor during any audit window.
Reasonable care as a defense
When CBP finds errors, they evaluate whether penalties are warranted. The penalty assessment considers whether the importer exercised reasonable care. This is where the distinction between evidence and opinion becomes financially material.
With reasonable care evidence: CBP finds a classification error affecting 200 entries over three years. The importer produces their classification procedure, shows the analysis they conducted, demonstrates that they consulted the relevant tariff notes, and explains that the error resulted from an ambiguity in the heading criteria that they resolved in good faith. CBP may issue a rate advancement (correcting the duty rate) without assessing penalties, or may reduce penalties significantly under the mitigation guidelines.
Without reasonable care evidence: CBP finds the same classification error. The importer has no documented classification procedure, no analysis, no evidence of the decision-making process. The error appears to result from inattention rather than good-faith analysis. CBP assesses penalties at the full statutory rate — which can reach 20% of the entered value for negligence, or 40% for gross negligence, on every affected entry.
The difference between these outcomes is not the error. It is the evidence.
What this means for the $50K–$250K exposure
The $50,000–$250,000 annual exposure that mid-size importers carry from documentation gaps is not a fixed cost. It is a range determined largely by whether the importer can demonstrate reasonable care when errors are found.
At the low end: an importer with documented processes, voluntary prior disclosures, and evidence of ongoing diligence. Errors are corrected, duties are paid, and penalties are minimal or mitigated entirely.
At the high end: an importer with no documented processes, no prior disclosures, and no evidence that anyone reviewed the compliance decisions being made on their behalf. Errors trigger full penalty assessments, retroactive duty collections, and possible referral for enhanced scrutiny on future entries.
Reasonable care is the mechanism that determines where on that spectrum an importer lands.
Building reasonable care into operations
Reasonable care is not a compliance project with a start and end date. It is an operational practice.
Start with the highest-risk entries. Products with the highest duty rates, the most complex classification, or the largest volume. Document the reasoning behind each compliance decision for these entries first.
Capture reasoning at the point of decision. When a classification is made, document why. When a valuation is calculated, record the method. When an origin is claimed, retain the supporting evidence. This is the upstream discipline described in Pre-Border Trade Readiness — evidence created at each step, not reconstructed after the fact.
Review when circumstances change. New products, new tariff rates, new suppliers, new trade agreements. Any change that could affect a compliance decision should trigger a review of the affected entries.
Voluntarily disclose errors. When you find a mistake, disclose it to CBP through the prior disclosure process before CBP finds it. Prior disclosure is the strongest evidence of reasonable care — it demonstrates that you monitor your own compliance and correct errors proactively.
Retain everything for five years. The classification analysis, the valuation calculation, the origin documentation, the internal review records, the prior disclosures. Organized by entry, retrievable on demand.
This is not about being right every time. It is about having a defensible process every time. Reasonable care is not a standard of perfection. It is a standard of evidence.
The importers who build that evidence into their trade operations — continuously, at every step, starting upstream — are the ones who turn reasonable care from a compliance obligation into a competitive advantage. When CBP asks why you classified a shipment the way you did, the best answer is not "because it's correct." The best answer is "here's the evidence."
See also: